VERMILLION INC | 1,190 Euro | -0,008 -0,67 % | |
| WKN: A0NFQV ISIN: US92407M2061 Ticker-Symbol: CUL1 | Frankfurt | 10.02.12 | 15:38 Uhr |
Branche GesundheitswesenAktienmarkt Sonstige |
|
| Zeit | Aktuelle Nachrichten | Leser | Medien | |
|---|---|---|---|---|
| 06.02. | Vermillion to Report Preliminary Results for Fourth Quarter and Fiscal Year 2011 on February 23, 2012 | 37 | PR Newswire | |
| AUSTIN, Texas, Feb. 6, 2012 /PRNewswire/ --Vermillion, Inc. (NASDAQ: VRML), a molecular diagnostics company focusing on oncology and cardiology, plans to report preliminary results for its fourth... Mehr lesen zu: Vermillion to Report Preliminary Results for Fourth Quarter and Fiscal Year 2011 on February 23, 2012 | ||||
| 04.01. | Vermillion Sharpens Focus and Streamlines Operations in 2012; To Reduce Headcount And Other Expenses | 6 | Benzinga.com | |
| 04.01. | Vermillion (VRML) to Streamline Ops, Will Reduce Overall Headcount | 1 | StreetInsider.com | |
| 04.01. | Vermillion Sharpens Focus and Streamlines Operations in 2012 | 12 | PR Newswire | |
| AUSTIN, Texas, Jan. 4, 2012 /PRNewswire/ -- Vermillion, Inc. (NASDAQ: VRML), a molecular diagnostics company focusing on cancer and cardiology, announced a plan to streamline its... Mehr lesen zu: Vermillion Sharpens Focus and Streamlines Operations in 2012 | ||||
| 19.12. | Vermillion Completes the Acquisition of Correlogic Systems' Ovarian Cancer Diagnostics Business | 8 | PR Newswire | |
| AUSTIN, Texas, Dec. 19, 2011 /PRNewswire/ --Vermillion, Inc. (NASDAQ: VRML), a leading molecular diagnostics company, has completed the purchase of substantially all of the assets associated... Mehr lesen zu: Vermillion Completes the Acquisition of Correlogic Systems' Ovarian Cancer Diagnostics Business | ||||
| 09.11. | VERMILLION, INC. - 10-Q, Quarterly Report | 2 | SEC Filings | |
| 09.11. | Vermillion Reports Results for Third Quarter 2011 | 18 | PR Newswire | |
| AUSTIN, Texas, Nov. 9, 2011 /PRNewswire/ -- Vermillion, Inc. (NASDAQ: VRML), a leading molecular diagnostics company, reported financial results for the third quarter ended September 30,2011.
Q3... Mehr lesen zu: Vermillion Reports Results for Third Quarter 2011 | ||||
| 07.11. | Vermillion to Present at Stephens Fall Investment Conference on November 16, 2011 | 6 | PR Newswire | |
| AUSTIN, Texas, Nov. 7, 2011 /PRNewswire/ -- Vermillion, Inc. (NASDAQ: VRML), a leading molecular diagnostics company, has been invited to present at the Stephens Fall Investment Conference. The conference... Mehr lesen zu: Vermillion to Present at Stephens Fall Investment Conference on November 16, 2011 | ||||
| 07.11. | Vermillion River Prospect Acquisition | 3 | wotnews | |
| 04.11. | Vermillion to Present at Lazard Capital Markets 8th Annual Healthcare Conference on November 15, 2011 | 18 | PR Newswire | |
| AUSTIN, Texas, Nov. 4, 2011 /PRNewswire/ -- Vermillion, Inc. (NASDAQ: VRML), a leading molecular diagnostics company, has been invited to present at the Lazard Capital Markets 8th Annual Healthcare... Mehr lesen zu: Vermillion to Present at Lazard Capital Markets 8th Annual Healthcare Conference on November 15, 2011 | ||||
| 03.11. | Vermillion Receives Notice of Allowance for 5th Biomarker Patent Related to Peripheral Artery Disease | 10 | PR Newswire | |
| AUSTIN, Texas, Nov. 3, 2011 /PRNewswire/ -- Vermillion, Inc. (NASDAQ: VRML), a leading molecular diagnostics company, has received a notice of allowance from the United States Patent and Trademark... Mehr lesen zu: Vermillion Receives Notice of Allowance for 5th Biomarker Patent Related to Peripheral Artery Disease | ||||
| 01.11. | Vermillion Engages Liolios Group to Lead Investor Relations Program | 18 | PR Newswire | |
| AUSTIN, Texas, Nov. 1, 2011 /PRNewswire/ -- Vermillion, Inc. (NASDAQ: VRML), a leading molecular diagnostics company, has engaged Liolios Group to lead a new investor relations and financial communications... Mehr lesen zu: Vermillion Engages Liolios Group to Lead Investor Relations Program | ||||
| 12.10. | Vermillion to Host Conference Call and Web Cast to Present Company Update and Review Financial Results for the Third Quarter 2011 | 30 | PR Newswire | |
| AUSTIN, Texas, Oct. 12, 2011 /PRNewswire/ -- Vermillion, Inc. (NASDAQ: VRML), a molecular diagnostics company, will host a web cast and conference call to give a company update following the issuance... Mehr lesen zu: Vermillion to Host Conference Call and Web Cast to Present Company Update and Review Financial Results for the Third Quarter 2011 | ||||
| 03.10. | Vermillion (VRML) Reports Strong Top-Line Results for VASCLIR | 1 | StreetInsider.com | |
| 03.10. | Vermillion Announces Positive Top-Line Data from Intended Use Study for Peripheral Artery Disease (PAD) | 11 | PR Newswire | |
| AUSTIN, Texas, Oct. 3, 2011 /PRNewswire/ -- Vermillion, Inc. (NASDAQ: VRML), a molecular diagnostics company, today announced positive top-line results from the intended use study for its peripheral... Mehr lesen zu: Vermillion Announces Positive Top-Line Data from Intended Use Study for Peripheral Artery Disease (PAD) | ||||
| 26.09. | Vermillion Enhances Management Team With A Key Addition | 33 | PR Newswire | |
| AUSTIN, Texas, Sept. 26, 2011 /PRNewswire/ -- Vermillion, Inc. (NASDAQ: VRML) a molecular diagnostics company, today announced the appointment of Donald Munroe, Ph.D. as Chief Scientific Officer and... Mehr lesen zu: Vermillion Enhances Management Team With A Key Addition | ||||
| 16.09. | Factors Moving Markets, Worldwide View - Equity Research on Vermillion, Inc. and OraSure Technologies, Inc. | 38 | MarketWire | |
| HONG KONG -- (Marketwire) -- 09/16/11 -- Today, www.WorldStreetFundamentals.com released its industry report highlighting Vermillion, Inc. (NASDAQ: VRML) and OraSure Technologies, Inc. (NASDAQ: OSUR).... Mehr lesen zu: Factors Moving Markets, Worldwide View - Equity Research on Vermillion, Inc. and OraSure Technologies, Inc. | ||||
| 06.09. | Vermillion Announces Issuance of Patent for Lung Cancer | 7 | PR Newswire | |
| AUSTIN, Texas, Sept. 6, 2011 /PRNewswire/ -- Vermillion, Inc. (NASDAQ: VRML), a molecular diagnostics company, today announced that the United States Patent and Trademark Office (USPTO) has issued... Mehr lesen zu: Vermillion Announces Issuance of Patent for Lung Cancer | ||||
Startseite • Nachrichten • Aktienkurse • Xetra-Orderbuch • Watchlist
Ad hoc-Mitteilungen • Chartanalysen • Nachrichten Börsen • Aktien-Empfehlungen
Branchen • Medien • Nachrichten-Archiv
Impressum | AGB | Disclaimer • Presse • Mediadaten
RSS-News von FinanzNachrichten.de kostenlos für Ihren Browser und Ihre Homepage
